Transfusion-related acute lung injury after the infusion of IVIG

Transfusion

Volumn 41, Issue 2, 2001, Pages 264-268

  Rizk, André ^a   Gorson, Kenneth C ^a   Kenney, Lawrence ^a   Weinstein, Robert ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1;

ADULT; ARTICLE; BLOOD COMPONENT THERAPY; CAPILLARY ENDOTHELIUM; CASE REPORT; CELL INTERACTION; HUMAN; HYPERVOLEMIA; IMMUNOTHERAPY; LUNG CAPILLARY; LUNG EDEMA; LUNG INJURY; MALE; MOTOR NEUROPATHY;

ADULT; AUTOIMMUNE DISEASES; BLOOD TRANSFUSION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFUSIONS, INTRAVENOUS; MALE; MOTOR NEURON DISEASE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0035107267     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41020264.x     Document Type: Article

References (48)

1. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies
2. Transfusion-related acute lung injury: A neglected, serious complication of hemotherapy
3. Transfusion-related acute lung injury
4. The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study
5. Transfusion-related acute lung injury (TRALI) after fresh frozen plasma in a patient with coagulopathy
6. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood
7. Transfusion-related acute lung injury following random donor platelet transfusion: A report of two cases
8. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases
9. Multifocal motor neuropathy: Response to human immune globulin
10. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study
11. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy
12. Intravenous immune globulin therapy for neurological diseases
13. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy
14. The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy
15. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases
16. Complications of intravenous immune globulin treatment in neurologic disease
17. Complications of intravenous immune globulin treatment in neurologic disease
18. Complications of intravenous gammaglobulin in neuromuscular and other diseases
19. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury
20. Transfusion-related acute lung injury caused by NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura
21. Transfusion-related acute lung injury in a patient with acute myelogenous leukemia having anti-IgA2m(1) antibody
22. Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria
23. Platelet activating factor primes neutrophil responses to agonists: Role in promoting neutrophil-mediated endothelial damage
24. Roles of the neutrophil and other mediators in adult respiratory distress syndrome
25. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock
26. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model
27. Transient neutropenia induced by intravenous immune globulin
28. Neonatal immune neutropenia following the administration of intravenous immune globulin
29. Neutropenia in a patient receiving intravenous immune globulin
30. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: Common and non-alarming
31. Microdroplet lymphocyte cytotoxicity test
32. A micro-technique for detection of leukocyte agglutinins
33. A microagglutination technique for detection of leukocyte agglutinins
34. Detection of neutrophil and platelet antibodies in immunologically induced neutropenia and thrombocytopenia
35. Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal antibody-specific immobilization of granulocyte antigens (MAIGA)
36. NA-phenotype-dependent differences in neutrophil FcγRIIIb expression cause differences in plasma levels of soluble FcγRIII
37. Challenges in the determination of clinically significant granulocyte antibodies and antigens
38. The detection of granulocyte alloantibodies with an indirect immunofluorescence test
39. Granulocyte serology. A clinical and laboratory guide
40. Basic principles of therapeutic blood exchange
41. Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung
42. Cytokine generation in stored platelet concentrates
43. The role of the plasma from platelet concentrates in transfusion reactions
44. An in vitro model of transfusion-mediated neutrophil cytotoxicity: The role of lipid priming agents in PMN activation
45. Reproduction of transfusion-related acute lung injury in an ex vivo lung model
46. Transfusion related acute lung injury
47. Noncardiogenic pulmonary edema triggered by intravenous immunoglobulin in cancer-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
48. A rare cause of intra-alveolar hemorrhage: A transfusion-related incident with leukoagglutination due to anti-granulocyte antibodies. (TRALI syndrome)